Steakholder Foods Ltd. — Form 6-K Summary
Business Context and Reporting Period
This Form 6-K covers January 2023 and reports the pricing and closing of an underwritten public offering by Steakholder Foods Ltd., an Israeli foreign private issuer. The offering closed on January 10, 2023, under a registration statement on Form F-1 declared effective January 5, 2023.
Offering and Key Financial Terms
- The company issued 1,550,000 American Depositary Shares (ADSs), with each ADS representing ten ordinary shares, at $1.00 per ADS.
- The offering also included pre-funded warrants to purchase 4,950,000 ADSs. Each pre-funded warrant had an exercise price of $0.0001 per ADS.
- Investors received warrants to purchase 6,500,000 ADSs. These warrants are immediately exercisable at $1.00 per ADS and expire January 10, 2028.
- The underwriter received a warrant to purchase 162,500 ADSs, representing 2.5% of the ADSs and pre-funded warrants sold.
- The underwriter received a 45-day over-allotment option for up to 975,000 additional ADSs and/or pre-funded warrants and 975,000 additional investor warrants.
- The company stated that expected net proceeds were approximately $6.5 million, excluding any exercise of the over-allotment option or warrants and before deducting estimated offering expenses payable by the company.
- Proceeds may be used for operating expenses, working capital, acquisitions, share repurchases, capital expenditures, and satisfaction of debt obligations.
Material Changes and Unusual Items
- On January 6, 2023, the company amended warrants held by Armistice Capital Master Fund Ltd. covering up to 1,857,143 ADSs.
- The exercise price of those warrants was reduced from $3.50 to $1.00 per ADS, and the expiration date was extended from July 5, 2027 to January 10, 2028.
- The offering and warrant amendment may create substantial potential dilution from the issuance of ADSs underlying the pre-funded warrants, investor warrants, the underwriter warrant, the amended Armistice warrants, and any over-allotment securities.
- Underwriting discounts and commissions were allocated 75% to A.G.P./Alliance Global Partners, the sole book-running manager, and 25% to Maxim Group LLC, the lead manager. The filing does not provide a specific dollar amount for these fees.
Financial Metrics, Liquidity, Outlook, and Risks
The filing does not provide revenue, profit or loss, cash flow, operating margin, debt balances, or other period-specific financial statements. It also does not provide formal financial guidance or a detailed operating outlook.
The financing is intended to support general corporate purposes and may fund operating needs and debt obligations. The company’s actual liquidity runway, cash balance after the offering, and remaining debt obligations are not stated in the filing text.
Key risks and contingencies include potential dilution from warrant exercises and the over-allotment option, underwriting indemnification and termination provisions, offering expenses, and the company’s discretion in allocating the proceeds. The filing does not state whether the over-allotment option or any warrants had been exercised as of January 10, 2023.
Facts Investors Should Verify
- Final gross proceeds, offering expenses, underwriting discounts, and net cash received.
- Whether the underwriter exercised its over-allotment option and the resulting securities outstanding.
- Current ADS and ordinary-share counts, including all shares issuable upon warrant and pre-funded warrant exercise.
- Outstanding debt and the portion of offering proceeds allocated to debt repayment.
- Cash balance, cash burn, and liquidity runway following the offering.
- Terms and potential impact of the Armistice warrant repricing and extension.